ibd Flashcards

1
Q

paragraph on IBD

A

use intro from IBD thing
allele nod2 has a 30.3 RR for ileal disease in homozygotes ( ahmed 2002)
van beelen 2007 found card15 may influence th177 and release of il17 in inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

why do we need therapeutics

A

induce and maintain remission
reduce hospitalisation
reduce illness symptoms and risk of complications
reduce costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

steroids
name 1
use
mode of delivery

A

[1] prednisone
used short term or in acutely ill due to side effects
orally, IV rectal delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

mode of action

A

inhibits cytokine production-proinflammatory such as iL1aplha
increase anti-inflammatory cytokines
suppress eiconsanoids inn phagocytic cells
supress COX2
work by binding in nucleus to glucocorticoid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

side effects

A
muscle wasting 
thinning of skin
increase appetite
increase infection 
osteoporosis
mania 
cataracts
abdominal mass 
easy bruising
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

5ASA

A
inhibits proinflammatory cytokines 
inhibition of cyoxygenase
scavenger free radical release
inhibit nfkbeta pathay
inhibit T cell proliferation, activation and differentiation 
impairs white cell function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

side effects

A
renal impairment 
diarrhoea 
headache 
malaise 
pancreatitis
intolerance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

name an immunmodulator and its other uses

A

azathioprine

AIH and RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

side effects

A

gi disturbances allergic reactons

heptosplenotoxicity fever rash fatigue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

methotrexate MOA

A

interfereswith dna synthesis
increase adenosine levels
increase apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

side effects

A
contraindicated in pregnancy 
bone marrow suppression 
rash
nausea 
diarrhoea 
hypersensitivity 
pneumonitis 
increased liver enzymes
fibrosis
cirrhosis 
no documentation of lymphoma or skin cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ciclosporine

A

UC
can be used as anti-tnf alternative
blocks cytokine gene in t cells
binds to calcineurin to inhibit IL2 from t cells productioon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

sid efects

A
hirituism 
gumhypertrophy
renal and heoatoxicity 
hypertension 
short term use onl
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

biologics

A

vedolizumab and ustekinemab new drugs

biologics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

USTEKINEMAB

A

inhibits IL12/23
cytokine receptor on t cell
used for porsiais but now approved for crohns
well tolerated less side effects
can be used on those contraindicated e.g. history of TP
sle
effecte in fisutaling disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

vedolizumab

A
anti integrin
binds to a4b7 preventing activation of madcam1
inhibition of inflamaoty cells
alternative of antiTNF
severe UC maybe
GUT SPECIFIC 
good for those with cancer history
17
Q

anti TNF
name 2
uses
side efects

A

humira (adalimumab)
infliximab
crohns over UC
demyelation ,malginacy, heart ailure, neutropenia
increase in MS and lupus
caution -elderly, those with MS, COPD, TB
can act with aziothprine syngestically

18
Q

new options

A

liquid diet therapy-good in short bowel and children,just as effective as steroids
antibiotics esp in sepsis
FMT- role of microbiome -studies at present

19
Q

smad 7 inhibitor
function of smad7
name one inhibitor

A

GED 0301
smad7 works to downregulate smad4 and tgfbeta therefore smad 7 inhbiitro increases TGFB pathway
decrease in IL1 tnfalpha

20
Q

tofaculimab

function

A
blocks stat phosphorylation 
inhibits jak1-3
decrease t and b cell activation 
modulates proinflammatory cytokines IL4,7,9,15,21 
does not affect tregs
21
Q

cotercosteroids vs immunosupressives

A

immunosupressives severe side effects, slow onset, intolerance

cortercosteroids have side effects, no maintainence ability, resistance and lack of mucosal healing
second line therapy for cd
ineffective in maintenance

22
Q

first line for uc

A

aminosalicyclates